COVID-19 Scenario Projections: The Emergence of Omicron in the US
| dc.creator | Bouchnita, Anass | |
| dc.creator | Fox, Spencer J. | |
| dc.creator | Lachmann, Michael | |
| dc.creator | Herrera-Diestra, Jose L. | |
| dc.creator | Gibson, Graham | |
| dc.creator | Meyers, Lauren Ancel | |
| dc.date.accessioned | 2024-07-29T20:41:42Z | |
| dc.date.available | 2024-07-29T20:41:42Z | |
| dc.date.issued | 2021-12 | |
| dc.description.abstract | On November 24, 2021, South African scientists announced the rapid spread of a new SARS-CoV-2 variant. Within days, the WHO named the variant Omicron and classified it as a variant of concern (VOC). As of December 15, 2021, many of Omicron's epidemiological characteristics remain uncertain, including its intrinsic transmissibility, ability to evade vaccine-acquired and infection-acquired immunity, and severity. To support situational awareness and planning in the United States, we simulated the emergence and spread of Omicron in the US across a range of plausible scenarios. Using a stochastic compartmental model that tracks population-level immunity against the Delta and Omicron variants derived from infections, primary vaccines, and booster vaccines, we project COVID-19 cases, hospitalizations and deaths over a six month period beginning on December 1, 2021 under 18 different scenarios. | |
| dc.description.department | Integrative Biology | |
| dc.identifier.doi | 10.15781/5kxe-ms96 | |
| dc.identifier.uri | https://hdl.handle.net/2152/126271 | |
| dc.identifier.uri | https://doi.org/10.26153/tsw/52808 | |
| dc.subject | COVID-19 | |
| dc.subject | projections | |
| dc.subject | omicron | |
| dc.subject | United States | |
| dc.title | COVID-19 Scenario Projections: The Emergence of Omicron in the US | |
| dc.type | DataPaper |